How have AIMD shares performed in 2023?

Ainos' stock was trading at $0.66 at the beginning of the year. Since then, AIMD stock has decreased by 9.3% and is now trading at $0.5989. View the best growth stocks for 2023 here .

Are investors shorting Ainos?

Ainos saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 25,800 shares, a drop of 6.9% from the October 31st total of 27,700 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is presently 0.8 days. Approximately 0.4% of the company's stock are short sold. View Ainos' Short Interest .

When is Ainos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our AIMD earnings forecast .

(AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

How do I buy shares of Ainos?

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Ainos Stock Price, News & Analysis (NASDAQ:AIMD)

$0.60

+0.00 (+0.15%)

(As of 05:11 PM ET)

Compare

Today's Range: $0.60
▼
$0.60
50-Day Range: $0.58
▼
$0.69
52-Week Range: $0.50
▼
$1.83

Volume: 66,413 shs
Average Volume: 349,087 shs
Market Capitalization: $12.15 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials SEC Filings Short Interest Social Media

About Ainos

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

AIMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AIMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive AIMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 11/28/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/29/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AIMD
CUSIP: N/A
CIK: 1014763
Web: www.ainos.com
Phone: 858-869-2986
Fax: 806-376-9301
Employees: 43
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,010,000.00
Net Margins: -874.50%
Pretax Margin: -874.41%
Return on Equity: -31.92%
Return on Assets: -28.16%

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 3.71
Quick Ratio: 3.45

Sales & Book Value

Annual Sales: $3.52 million
Price / Sales: 3.45
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.73 per share
Price / Book: 0.35

Miscellaneous

Outstanding Shares: 20,290,000
Free Float: 19,370,000
Market Cap: $12.15 million
Optionable: Not Optionable
Beta: 1.32

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Chun-Hsien Tsai (Age 53)
Chairman of Board, President & CEO
Comp: $116.96k
Mr. Lawrence Kennedy Lin (Age 54)
Executive Vice President of Operations
Comp: $133.02k
Ms. Meng-Lin Sung
Chief Financial Officer
Mr. John Junyong Lee Esq. (Age 56)
Chief Legal Counsel, Corporate Counsel & Secretary
Mr. Chih-Heng Lu (Age 43)
Director of Corporate Developoment

Key Competitors

View All Competitors

AIMD Stock Analysis - Frequently Asked Questions

How have AIMD shares performed in 2023?: Ainos' stock was trading at $0.66 at the beginning of the year. Since then, AIMD stock has decreased by 9.3% and is now trading at $0.5989.
View the best growth stocks for 2023 here.
Are investors shorting Ainos?: Ainos saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 25,800 shares, a drop of 6.9% from the October 31st total of 27,700 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is presently 0.8 days. Approximately 0.4% of the company's stock are short sold.
View Ainos' Short Interest.
When is Ainos' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our AIMD earnings forecast.

When did Ainos IPO?: (AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.
How do I buy shares of Ainos?: Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AIMD) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial